Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.
Inflammatory neuropathies encompass groups of heterogeneous disorders characterized by pathogenic immune-mediated hematogenous leukocyte infiltration of peripheral nerves, nerve roots or both, with resultant demyelination or axonal degeneration or both. Inflammatory neuropathies may be divided into three major disease categories: Guillain-Barré syndrome (particularly the acute inflammatory demyelinating polyradiculoneuropathy variant), chronic inflammatory demyelinating polyradiculoneuropathy and nonsystemic vasculitic neuropathy (or peripheral nerve vasculitis). Despite major advances in molecular biology, pathology and genetics, the pathogenesis of these disorders remains elusive. There is insufficient knowledge on the mechanisms of hematogenous leukocyte trafficking into the peripheral nervous system to guide the development of specific molecular therapies for immune-mediated inflammatory neuropathies compared to disorders such as psoriasis, inflammatory bowel disease, rheumatoid arthritis or multiple sclerosis. The recent isolation and characterization of human endoneurial endothelial cells that form the blood-nerve barrier provides an opportunity to elucidate leukocyte-endothelial cell interactions critical to the pathogenesis of inflammatory neuropathies at the interface between the systemic circulation and peripheral nerve endoneurium. This review discusses our current knowledge of the classic pathological features of inflammatory neuropathies, attempts at molecular classification and genetic determinants, the utilization of in vitro and in vivo animal models to determine pathogenic mechanisms at the interface between the systemic circulation and the peripheral nervous system relevant to these disorders and prospects for future potential molecular pathology biomarkers and targets for specific therapeutic intervention.
Neuromuscular Immunopathology Research Laboratory, Division of Neuromuscular Disease, Department of Neurology, The University of Alabama at Birmingham, 1720 7th Avenue South, Sparks Center 200, Birmingham, AL, 35294-0017, USA. ubogu@uab.edu.
Eroboghene E
EE
Ubogu
D000818:Animals; D020274:Autoimmune Diseases of the Nervous System / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000628:therapy*; D015415:Biomarkers / Q000378:metabolism; D006801:Humans; D007962:Leukocytes / Q000502:physiology
D015415:Biomarkers
Blood–nerve barrier; Chronic inflammatory demyelinating polyradiculoneuropathy; Genetic polymorphisms; Guillain–Barré syndrome; Inflammation; Leukocyte trafficking; Mechanisms; Pathology; Peripheral nerves; Vasculitic neuropathies